Korea Investment CORP Has $3.80 Million Stock Position in Molina Healthcare, Inc $MOH

Key Points

• Korea Investment CORP cut its stake in Molina Healthcare by 31.2%, selling 9,000 shares and ending the quarter with 19,830 shares worth about $3.795 million.
• Molina reported a significant Q loss of ($2.75) EPS versus $0.43 expected, though revenue beat at $11.38 billion (up 8.3% YoY), and the company set FY2026 guidance around $5.00 EPS.
• Wall Street is mixed—two Buys, ten Holds and two Sells yield an average rating of Hold with a $153.29 target, while the stock trades near $149.27 and the company has a market cap of about $7.69 billion.

Korea Investment CORP lowered its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 31.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 19,830 shares of the company's stock after selling 9,000 shares during the period. Korea Investment CORP's holdings in Molina Healthcare were worth $3,795,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Grantham Mayo Van Otterloo & Co. LLC increased its holdings in shares of Molina Healthcare by 1,863.7% during the third quarter. Grantham Mayo Van Otterloo & Co. LLC now owns 43,202 shares of the company's stock valued at $8,267,000 after acquiring an additional 41,002 shares in the last quarter. First Trust Advisors LP lifted its holdings in shares of Molina Healthcare by 10.7% in the 3rd quarter. First Trust Advisors LP now owns 109,039 shares of the company's stock worth $20,866,000 after purchasing an additional 10,572 shares in the last quarter. HUB Investment Partners LLC bought a new position in shares of Molina Healthcare in the 3rd quarter worth $355,000. Aptus Capital Advisors LLC grew its position in Molina Healthcare by 52.3% in the 3rd quarter. Aptus Capital Advisors LLC now owns 1,168 shares of the company's stock valued at $224,000 after purchasing an additional 401 shares during the period. Finally, Orion Porfolio Solutions LLC grew its position in Molina Healthcare by 5.6% in the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,000 shares of the company's stock valued at $1,340,000 after purchasing an additional 370 shares during the period. Institutional investors and hedge funds own 98.50% of the company's stock.

Molina Healthcare Price Performance

MOH opened at $149.27 on Friday. Molina Healthcare, Inc has a 1 year low of $121.06 and a 1 year high of $359.97. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.69 and a quick ratio of 1.69. The company has a market capitalization of $7.69 billion, a price-to-earnings ratio of 17.44 and a beta of 0.52. The firm's fifty day moving average price is $164.22 and its two-hundred day moving average price is $167.35.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The firm had revenue of $11.38 billion during the quarter, compared to analysts' expectations of $10.90 billion. During the same quarter in the prior year, the company earned $5.05 EPS. The business's revenue for the quarter was up 8.3% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. UBS Group upped their price objective on shares of Molina Healthcare from $145.00 to $151.00 and gave the stock a "neutral" rating in a report on Thursday. Deutsche Bank Aktiengesellschaft set a $109.00 price objective on shares of Molina Healthcare in a report on Tuesday, February 10th. Mizuho decreased their target price on shares of Molina Healthcare from $220.00 to $180.00 and set an "outperform" rating for the company in a research report on Thursday. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Molina Healthcare in a research report on Thursday, January 22nd. Finally, Barclays cut their price target on Molina Healthcare from $164.00 to $133.00 and set an "underweight" rating for the company in a research note on Tuesday, February 10th. Two investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $153.29.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.